iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.
iSpecimen has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
iSpecimen's investors include MassChallenge.
iSpecimen is headquartered in Lexington, United States.
iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.
iSpecimen is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iSpecimen — Funding & Investors." VCBacked, May 8, 2026, https://www.vcbacked.co/company/ispecimen. Accessed July 19, 2026.
VCBacked. (2026). iSpecimen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ispecimen
{{cite web |title=iSpecimen — Funding & Investors |url=https://www.vcbacked.co/company/ispecimen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated